Your browser doesn't support javascript.
loading
Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.
Felth, Jenny; Lesiak-Mieczkowska, Karolina; D'Arcy, Padraig; Haglund, Caroline; Gullbo, Joachim; Larsson, Rolf; Linder, Stig; Bohlin, Lars; Fryknäs, Mårten; Rickardson, Linda.
Afiliação
  • Felth J; Division of Pharmacognosy, Department of Medicinal Chemistry, Biomedical Center, Uppsala University, Uppsala, Sweden. jenny@felth.se
Invest New Drugs ; 31(3): 587-98, 2013 Jun.
Article em En | MEDLINE | ID: mdl-23179339
ABSTRACT
Gambogic acid (GA), displays cytotoxicity towards a wide variety of tumor cells and has been shown to affect many important cell-signaling pathways. In the present work, we investigated the mechanism of action of GA by analysis of drug-induced changes in gene expression profiles and identified GA and the derivative dihydro GA as possible inhibitors of the ubiquitin-proteasome system (UPS). Both GA and dihydro GA inhibited proteasome function in cells resulting in the accumulation of polyubiquitin complexes. In vitro experiments showed that both GA and dihydro GA inhibited 20S chymotrypsin activity and the inhibitory effects of GA and dihydro GA on proteasome function corresponded with apoptosis induction and cell death. In conclusion, our results show that GA and dihydro GA exert their cytotoxic activity through inhibition of the UPS, specifically by acting as inhibitors of the chymotrypsin activity of the 20S proteasome.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Xantonas / Inibidores de Proteassoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Xantonas / Inibidores de Proteassoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Suécia